Journal article

Leptin Plasma Concentrations Increase During Antidepressant Treatment With Amitriptyline and Mirtazapine, But Not Paroxetine and Venlafaxine Leptin Resistance Mediated by Antihistaminergic Activity?


Authors listSchilling, Claudia; Gilles, Maria; Blum, Werner F.; Daseking, Emmerich; Colla, Michael; Weber-Hamann, Bettina; Lederbogen, Florian; Krumm, Bertram; Heuser, Isabella; Wudy, Stefan A.; Kopf, Daniel; Deuschle, Michael

Publication year2013

Pages99-103

JournalJournal of Clinical Psychopharmacology

Volume number33

Issue number1

ISSN0271-0749

eISSN1533-712X

DOI Linkhttps://doi.org/10.1097/JCP.0b013e31827cb179

PublisherLippincott, Williams & Wilkins


Abstract
Treatment with several psychopharmacological agents has been associated with increased leptin plasma concentrations. We measured leptin plasma concentrations in 76 adult depressed patients after a 6-day washout phase and again after 35 days of treatment with amitriptyline or paroxetine, as well as in 73 depressed patients after 28 days of treatment with either mirtazapine or venlafaxine. Leptin plasma concentrations increased during treatment with amitriptyline and mirtazapine, even after controlling for increased body mass index and irrespective of response to treatment [14.5 (13.8) vs 20.3 (18.7) ng/mL, and 12.2 (15.8) vs 14.4 (16.5) ng/mL in the 2 cohorts, respectively]. In contrast, paroxetine and venlafaxine treatment was not associated with changes in leptin plasma concentrations [14.8 (12.0) vs 13.6 (10.6); 15.9 (17.3) vs 13.5 (14.6) ng/mL] nor with weight gain. We conclude that treatment with amitriptyline or mirtazapine is associated with an increase in leptin secretion beyond change in weight. Thus, high leptin levels apparently are ineffective in the control of weight gain, indicating leptin resistance. Leptin resistance may be mediated by an antihistaminergic effect on hypothalamic nuclei integrating signals relevant for energy balance.



Citation Styles

Harvard Citation styleSchilling, C., Gilles, M., Blum, W., Daseking, E., Colla, M., Weber-Hamann, B., et al. (2013) Leptin Plasma Concentrations Increase During Antidepressant Treatment With Amitriptyline and Mirtazapine, But Not Paroxetine and Venlafaxine Leptin Resistance Mediated by Antihistaminergic Activity?, Journal of Clinical Psychopharmacology, 33(1), pp. 99-103. https://doi.org/10.1097/JCP.0b013e31827cb179

APA Citation styleSchilling, C., Gilles, M., Blum, W., Daseking, E., Colla, M., Weber-Hamann, B., Lederbogen, F., Krumm, B., Heuser, I., Wudy, S., Kopf, D., & Deuschle, M. (2013). Leptin Plasma Concentrations Increase During Antidepressant Treatment With Amitriptyline and Mirtazapine, But Not Paroxetine and Venlafaxine Leptin Resistance Mediated by Antihistaminergic Activity?. Journal of Clinical Psychopharmacology. 33(1), 99-103. https://doi.org/10.1097/JCP.0b013e31827cb179



Keywords


amitriptylineantihistaminergicDEPRESSED-PATIENTSHISTAMINEINDUCED SUPPRESSIONmirtazapineparoxetineSYMPTOMSvenlafaxine

Last updated on 2025-21-05 at 18:39